000 00730nam a2200205Ia 4500
999 _c3042
_d3042
005 20190503111138.0
008 180803s9999 xx 000 0 und d
020 _a0-471-52141-8
040 _aAIKTC-KRRC
_cAIKTC-KRRC
041 _aENG
082 _a615.19
_bLED/MIT
_2DDC23
100 _aLednicer, Daniel
_94181
245 0 _aOrganic chemistry of drug synthesis
250 _a1st
260 _aNew Delhi
_bJohn Wiley & Sons
_c1977
300 _axvii, 471 Pages
_bCard Paper
520 _aUpdated every five years, the series represents the optimal compromise between currency and a sufficient body of material for cohesive and comprehensive treatment in a monograph. Provides a quick yet thorough overview of the synthetic routines that have been used to access specific classes of therapeutic agents. Materials are organized by chemical class, and syntheses are taken back to available starting materials. Discusses disease state, rational for method of drug therapy, biological activities of each compound and preparation. Coverage also includes those generic pharmaceutical compounds not accorded clinical status. A glossary defines biological terms.
650 0 _95008
_aPHARMACEUTICAL CHEMISTRY
653 _aORGANIC CHEMISTRY OF DRUG SYNTHESIS
700 _aMitscher, Lester A.
_94182
856 _uhttps://ndl.iitkgp.ac.in/result?q={%22t%22:%22search%22,%22k%22:%22pharmaceutical%20chemistry%22,%22s%22:[%22DDC=\%22600%3A%3ATechnology\%22%22],%22b%22:{%22filters%22:[]}}
942 _cBK
_2ddc